Paul Tudor Jones Abbott Laboratories Call Options Transaction History

Tudor Investment Corp Et Al

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $3.82 Million - $4.51 Million	38,200 Added 553.62%	45,100 $5.14 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $5.05 Million - $5.63 Million	-50,100 Reduced 87.89%	6,900 $716,000
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $1.94 Million - $2.14 Million	17,700 Added 45.04%	57,000 $6.48 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $3.54 Million - $4.34 Million	39,300 New	39,300 $4.33 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $2.75 Million - $3.07 Million	27,300 New	27,300 $2.98 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $693,938 - $814,096	7,300 Added 41.71%	24,800 $2.72 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $1.51 Million - $1.75 Million	15,600 Added 821.05%	17,500 $1.69 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $20,414 - $24,674	200 Added 11.76%	1,900 $206,000
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $46,212 - $56,584	-400 Reduced 19.05%	1,700 $239,000
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $244,986 - $271,026	2,100 New	2,100 $249,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.